Old Web
English
Sign In
Acemap
>
authorDetail
>
T. Milenkova
T. Milenkova
Medicine
Cancer research
Gefitinib
VEGF receptors
in patient
2
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial
2020
P. Harter
D. Petran
G. Scambia
E. Ortega
I Tsibulak
S Nagao
I. Vergote
Jérôme Meunier
F. Priou
R. Sverdlin
T. Milenkova
I. L. Ray-Coquard
Show All
Source
Cite
Save
Citations (6)
Phase I evaluation of AZD2171, a highly potent, selective VEGFR signaling inhibitor, in combination with gefitinib, in patients with advanced tumors
2006
Journal of Clinical Oncology
H. van Cruijsen
Emile E. Voest
C.M.L. van Herpen
K. Hoekman
Petronella O. Witteveen
Manuel Tjin-A-Ton
C.J.A. Punt
T. Puchalski
T. Milenkova
G. Giaccone
Show All
Source
Cite
Save
Citations (16)
1